Clearside Biomedical
Latest round
- Series C
Last raised
- Dec 2015
Total raised
- $51M
Investors
- 11
About Clearside Biomedical
Clearside Biomedical, Inc.Founded in 2012 and headquartered in Alpharetta, US, Clearside Biomedical, Inc. develops advanced drug delivery technologies for ocular treatments.Clearside Biomedical is known for its proprietary suprachoroidal delivery system and its flagship product, XIPERE® (triamcinolone acetonide injectable suspension). This innovative FDA-approved treatment delivers medication directly to the suprachoroidal space, targeting conditions such as macular edema associated with uveitis. The company aims to expand its market presence internationally while further developing its pipeline of ocular therapies.
Who invested in Clearside Biomedical
11 investors across 5 rounds
See all investors in Clearside Biomedical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Clearside Biomedical
Who invested in Clearside Biomedical?
Clearside Biomedical has 11 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Clearside Biomedical raised?
Clearside Biomedical has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Clearside Biomedical last raise money?
Clearside Biomedical's most recent round on record is a Series C, in Dec 2015.
What does Clearside Biomedical do?
Clearside Biomedical is a biotechnology company.
Where is Clearside Biomedical headquartered?
Clearside Biomedical is headquartered in Alpharetta, US.
Which VCs invest in companies like Clearside Biomedical?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Clearside Biomedical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Clearside Biomedical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.